These analyses showed that a high level of GCC2-AS1 expression was strongly correlated with shorter OS time among patients with T stage (Figure 6A), N stage (Figure 6B), M stage (Figure 6C), pathological stage (Figure 6D), tumor status (Figure 6E), TP53 status (Figure 6F), and KRAS status (Figure 6G). This evidence concerns the gene TP53 and neoplasm.